STUDY OF PRESCRIPTION PATTERN ANALYSIS OF DRUGS USED IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN A TERTIARY CARE HOSPITAL: AN OBSERVATIONAL STUDY

Main Article Content

Sushma Naidu V
Vibha Rani

Keywords

Rheumatoid arthritis, Prescription analysis, DMARD

Abstract

Objective: This study was conducted to analyse the prescription pattern of Rheumatoid arthritis in a tertiary care hospital in India.


Methodology: The study was conducted in 180 patients of Rheumatoid arthritis who were given various forms of therapy and fulfilled the inclusion and exclusion criteria. Data was collected in case report format and the prescription pattern was analysed using patient’s demographic details, presence of comorbidities, usage of complementary and alternative medicine, details of drugs prescribed with dosage and combination therapies


Results: The results of this study showed that DMARDs were the most commonly prescribed drugs out of which Methotrexate was the preferred drug. Monotherapy was given in 34.5% of patients while DMARD dual combination was given in 61% of patients which contributed to the majority of the prescription. A triple DMARD therapy was given in only 4.5% of patients. Methotrexate was the most commonly prescribed DMARD either in monotherapy or in combination and constituted 87.6% of prescriptions 


Combination therapy of Methotrexate and Hydroxychloroquine covered the maximum number of prescriptions (68%). Sulfasalazine and Leflunomide were given in 29% and 3% of patients respectively. The prescriptions also included NSAIDs, Calcium and Vitamin D3 supplements as most common additional drugs followed by PPIs. Corticosteroids like Prednisolone were given in 12.5% of patients and were mostly preferred in long standing and refractory cases.


Conclusion:


Methotrexate is the most prescribed DMARD, often used in combination to enhance efficacy. DMARD combination of Methotrexate and HCQ was the most commonly used regimen compared to monotherapy and triple-drug therapy. 

Abstract 18 | Pdf Downloads 3

References

1. Siddiqui, A. Riyaz; Quazi, Shadma; Khan, Sharjeel; Shende, Tanaji R Drug Prescription Patterns and Quality of Life in Rheumatoid Arthritis Patients at a Tertiary Care Teaching Hospital in Central India: A Cross-Sectional StudyJournal of Datta Meghe Institute of Medical Sciences University 18(3):p 422-426, Jul–Sep 2023.
2. Gauri Mittal, Manisha Bisht, Venkatesh S. Pai, Shailendra S. Handu. Evaluation of prescription practices in rheumatoid arthritis at the rheumatology clinic in a tertiary care teaching hospital in Uttarakhand: A cross sectional study Journal of Family Medicine and Primary Care Volume 10 : Issue 2 : February 2021
3. Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2023;82:3-18..
4. Gerd R. Burmester, Filip Van den Bosch, John Tesser, Anna Shmagel, Yanxi Liu, Nasser Khan, Heidi S. Camp and Alan Kivitz. Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years. The Journal of Rheumatology July 2024, 51 (7) 663-672;
5. Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.The Journal of Rheumatology May 2024, 51 (5) 452-461.
6. Singh JA, Saag KG, Bridges SL, Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. ;Arthritis Rheumatol. 2016 68:1–26
7. Jasani K, Jain P, Patel D, Pandya S, Rana D, Malhotra S. Evaluation of drug use pattern and
quality of life in patients suffering from rheumatoid arthritis –A cross-sectional study at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol 2019;10:1.
8. Klareskog L, Rönnelid J, Saevarsdottir S, Padyukov L, Alfredsson L. The importance of
differences; On environment and its interactions with genes and immunity in the causation of rheumatoid arthritis. J Intern Med. 2020 May;287(5):514-533
9. Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple disease-modifying
antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med. 1999 Nov 16;131(10):768-74
10. DuttaSB, BegMA, BawaS, KaurA, VishalS. Prescribing pattern in Rheumatoid Arthritis patients in a tertiary care teaching hospital.Int JBasic Clin Pharmacol 2017;6:1486-90.
11. JebastineMI,NasmiN,EliasN,NeethuVV,ArulB.Prescription pattern of drugs used in management of rheumatoid arthritis in a tertiary care hospital: A retrospective study. IndoAm.J.Pharm.Sci.2015;2(8):1198-205
12.DahiyaA, KalraBS, SainiA, TekurU. Prescription pattern in patients with rheumatoid arthritis
in a tertiary care teaching hospital. MAMC J of Med Sci.2016;2:33